newsfilter
← Latest News
PR Newswire·

Viracta Therapeutics to be Added to the Nasdaq Biotechnology Index

SAN DIEGO, Dec. 16, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ:NBI)